Research Development - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Research & Development Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Research & Development
-€20.9m
CAGR 3-Years
-51%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Research & Development
-€93m
CAGR 3-Years
11%
CAGR 5-Years
-29%
CAGR 10-Years
-14%
Nanobiotix SA
PAR:NANO
Research & Development
-€37.1m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-20%
Innate Pharma SA
PAR:IPH
Research & Development
-€47.1m
CAGR 3-Years
-12%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Research & Development
-€35.9m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Research & Development
-€5.9m
CAGR 3-Years
-38%
CAGR 5-Years
-33%
CAGR 10-Years
2%

See Also

What is Maat Pharma SA's Research & Development?
Research & Development
-20.9m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Research & Development amounts to -20.9m EUR.

What is Maat Pharma SA's Research & Development growth rate?
Research & Development CAGR 5Y
-36%

Over the last year, the Research & Development growth was -46%. The average annual Research & Development growth rates for Maat Pharma SA have been -51% over the past three years , -36% over the past five years .

Back to Top